Institutional Ownership
Moleculin Biotech Inc
CUSIP 60855D408COMMBRXQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
17
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Sabby Management, LLC | 75.0K | $171.8K |
| 2 | Geode Capital Management, LLC | 32.3K | $74.0K |
| 3 | Rockefeller Capital Management L.P. | 4.4K | $10.1K |
| 4 | Ubs Group AG | 3.4K | $7.8K |
| 5 | Tower Research Capital LLC (Trc) | 1.8K | $4.2K |
| 6 | Blackrock, Inc. | 491 | $1.1K |
| 7 | Efg International AG | 434 | $994 |
| 8 | Pinnacle Wealth Planning Services, Inc. | 281 | $643 |
| 9 | Nfsg Corp | 114 | $261 |
| 10 | Sbi Securities Co., Ltd. | 43 | $98 |